< Back to companies
Woebot Health

Woebot Health

AI mental health at scale

San Francisco, CA, United States

Woebot Health, founded in 2014 and headquartered in San Francisco, California, develops digital therapeutics and mental wellness applications using conversational AI chatbots. It specializes in cognitive behavioral therapy (CBT), interpersonal psychotherapy (IPT), and dialectical behavior therapy (DBT). The company pivoted its business model in mid-2025 from direct-to-consumer to enterprise-focused.

Woebot Health logo
Only accessible to MedStartr community members. Join now

How We Help

Problem Statement

Woebot Health develops digital therapeutics and mental wellness applications using conversational AI chatbots to provide mental health support based on cognitive behavioral therapy (CBT), interpersonal psychotherapy (IPT), and dialectical behavior therapy (DBT).

Core Technology

conversational AI chatbots

Key Differentiators

FDA Breakthrough Device Designation for its postpartum depression digital therapeutic (WB001); Specializes in cognitive behavioral therapy (CBT), interpersonal psychotherapy (IPT), and dialectical behavior therapy (DBT) delivered via smartphone-based chatbot interfaces; Pivoted to an enterprise-focused B2B model, targeting payers, providers, and employers; Offers an enterprise platform including Woebot for Adults, Woebot for Adolescents, and Woebot for Maternal Health; ISO:13485-certified quality management system and HIPAA compliant

Clinical Focus

mental health; cognitive behavioral therapy; interpersonal psychotherapy; dialectical behavior therapy

Company Info

Business Model
B2B SaaS
Founded
2014
Total Funding
Only accessible to MedStartr community members. Join now
Website
woebothealth.com/

Categories

Behavioral Health

Disease Areas

Technologies

AIDigital Therapeutics

Clinical & IP

🔬

Clinical Validation

FDA Breakthrough Device Designation (WB001 for postpartum depression). Pivotal RCT ongoing for postpartum depression. Published RCTs in JMIR and PMC: 44% depression symptom reduction in young adults; 70% postpartum depression users achieved clinical improvement. HIPAA compliant; ORCHA certified.

Only accessible to MedStartr community members. Join now

What do you think of Woebot Health?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now